All In Biotech

Drug Trial Radar · NCT00002186

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

400

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
Shaman PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety of topically applied SP-303 gel and to compare the efficacy of SP-303 gel in combination with acyclovir, relative to acyclovir alone, for the treatment of recurrent Herpes Simplex Virus (HSV) 1 and 2 infections, affecting the genital, perianal and neighboring areas, in patients with AIDS.

Conditions

  • Herpes Simplex
  • HIV Infections

Interventions

  • CrofelemerDrug

  • AcyclovirDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

34 sites in 2 countries. Site status is shown where the registry gives one.

  • Sorra Research Ctr Inc / Med Forum

    Birmingham, Alabama

  • Hill Top Research Ltd

    Scottsdale, Arizona

  • Arizona Clinical Research Ctr Inc

    Tucson, Arizona

  • Dermatology SVC - VAMC

    Long Beach, California

  • King - Drew Med Ctr / Dept of Dermatology

    Los Angeles, California

  • Summit Med Ctr / Adult Immunology Clinic

    Oakland, California

  • ViRx Inc

    Palm Springs, California

  • ViRx Inc

    San Francisco, California

  • Conant Med Ctr

    San Francisco, California

  • Olive View Med Ctr

    Sylmar, California

  • Novum Inc

    Washington D.C., District of Columbia

  • IDC Research Initiative

    Altamonte Springs, Florida

  • Gary Richmond MD

    Fort Lauderdale, Florida

  • Dr Robert Schwartz

    Fort Myers, Florida

  • Infectious Disease Research Institute Inc

    Tampa, Florida

  • Treasure Coast Infectious Disease Consultants

    Vero Beach, Florida

  • Veterans Affairs Med Ctr of North Chicago

    Chicago, Illinois

  • Johns Hopkins Univ / Division of Infectious Disease

    Baltimore, Maryland

  • Saint Agnes Healthcare / Dept of Surgery

    Baltimore, Maryland

  • Massachusetts Gen Hosp - Warren 505

    Boston, Massachusetts

  • Medicine / Infectious Diseases

    Minneapolis, Minnesota

  • AIDS Ctr / Saint Vincents Hosp and Med Ctr

    New York, New York

  • New York Univ Med Ctr

    New York, New York

  • Mount Sinai Med Ctr

    New York, New York

  • Columbia Presbyterian Med Ctr

    New York, New York

  • Paddington Testing Co Inc

    Philadelphia, Pennsylvania

  • Austin Infectious Disease Consultants

    Austin, Texas

  • N Texas Ctr for AIDS & Clin Rsch

    Dallas, Texas

  • Division of Infectious Diseases / Univ of Texas - Houston

    Houston, Texas

  • Dr Robert Holman

    Arlington, Virginia

  • Novum Inc

    Seattle, Washington

  • Univ of Washington Virology Research Clinic

    Seattle, Washington

  • Hosp Regional de Ponce - Area Vieja

    Ponce, Puerto Rico

  • San Juan AIDS Program

    Santurce, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.